breast cancer screening

ResAppDx, a mobile respiratory diagnostic test app by Australian startup ResApp
Roundup: Pfizer finalises ResApp acquisition and more briefs
By Adam Ang | 01:28 am | September 30, 2022
Also, a new research centre at the University of Melbourne will use AI to advance breast cancer screening.
A clinician looking at a reading by Annalise CXR
Roundup: harrison.ai launches JV with Sonic Healthcare and more partnership briefs
By Adam Ang | 03:48 am | July 08, 2022
Also, annalise.ai has made key executive appointments to support its global expansion.
The SoftVue 3D Whole Breast Ultrasound Tomography System
Delphinus receives FDA clearance for ultrasound breast cancer screening tech
By Mallory Hackett | 12:55 pm | October 12, 2021
The SoftVue system is intended to be used in addition to digital mammograms to screen for cancer among patients with dense breast tissue.
doctor conducting a mammogram
Volpara Health lands additional FDA clearance for breast cancer detection product
By Mallory Hackett | 03:14 pm | August 02, 2021
This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.  
Radiologist examining a mammogram scan on a monitor
Whiterabbit emerges from stealth with FDA clearance for AI breast cancer screening tool
By Mallory Hackett | 02:10 pm | May 11, 2021
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection.   
breast cancer detection
Analysis system for breast cancer diagnosis solves ‘blackbox algorithm’ problem
By Tammy Lovell | 07:13 am | March 29, 2021
The system uses heatmaps to make AI decisions transparent to clinicians.
Volpara is purchasing all outstanding equity of CRA for $18 million and will pay an additional $4 million if certain strategic targets are met within 18 months.
Volpara Health acquires fellow breast cancer prevention company CRA Health
By Mallory Hackett | 02:08 pm | February 18, 2021
Volpara is purchasing all outstanding equity of CRA for $18 million and will pay an additional $4 million if certain strategic targets are met within 18 months.